StockData
Xtant Medical Holdings, Inc. logo

Xtant Medical Holdings, Inc. (XTNT) stock

XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3080% below fair value
$0.21−0.00 (-2.19%)

Close on Nov 17, 2026Market cap $28.79MP/E –Yield –

Xtant Medical operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Xtant Medical's operating cash flow for the twelve months ending Jun 30, 2026 was $570.00K, down 62.0% year over year. For fiscal 2025 it was $12.55M. The highest annual figure on record is $12.55M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$12.55M–
FY2024Dec 31, 2024-$11.90M–
FY2023Dec 31, 2023-$9.52M–
FY2022Dec 31, 2022-$5.34M-1316.6%
FY2021Dec 31, 2021$439.00K–
FY2020Dec 31, 2020-$731.00K–
FY2019Dec 31, 2019-$413.00K-134.1%
FY2018Dec 31, 2018$1.21M–
FY2017Dec 31, 2017-$543.00K–
FY2016Dec 31, 2016-$14.41M–
FY2015Dec 31, 2015-$9.10M–
FY2014Dec 31, 2014-$7.32M–
FY2013Dec 31, 2013-$4.89M–
FY2012Dec 31, 2012-$10.79M–
FY2011Dec 31, 2011-$7.36M–
FY2010Dec 31, 2010-$8.37M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.31M-672.7%
Q1 FY2026Mar 31, 2026-$2.11M-265.4%
Q4 FY2025Dec 31, 2025$5.38M+709.0%
Q3 FY2025Sep 30, 2025$4.61M–
Q2 FY2025Jun 30, 2025$1.28M–
Q1 FY2025Mar 31, 2025$1.28M–
Q4 FY2024Dec 31, 2024$665.00K–
Q3 FY2024Sep 30, 2024-$1.72M–
Q2 FY2024Jun 30, 2024-$5.09M–
Q1 FY2024Mar 31, 2024-$5.76M–
Q4 FY2023Dec 31, 2023-$915.00K–
Q3 FY2023Sep 30, 2023-$3.83M–
Q2 FY2023Jun 30, 2023-$2.52M-16906.7%
Q1 FY2023Mar 31, 2023-$2.25M–
Q4 FY2022Dec 31, 2022-$2.29M-640.9%
Q3 FY2022Sep 30, 2022-$2.06M–
Q2 FY2022Jun 30, 2022$15.00K-99.3%
Q1 FY2022Mar 31, 2022-$1.00M–
Q4 FY2021Dec 31, 2021$423.00K-53.8%
Q3 FY2021Sep 30, 2021-$926.00K–
Q2 FY2021Jun 30, 2021$2.25M+955.9%
Q1 FY2021Mar 31, 2021-$1.31M–
Q4 FY2020Dec 31, 2020$916.00K–
Q3 FY2020Sep 30, 2020-$71.00K–
Q2 FY2020Jun 30, 2020$213.00K-54.1%
Q1 FY2020Mar 31, 2020-$1.79M-465.1%
Q4 FY2019Dec 31, 2019-$71.00K-103.6%
Q3 FY2019Sep 30, 2019-$1.30M–
Q2 FY2019Jun 30, 2019$464.00K+329.6%
Q1 FY2019Mar 31, 2019$490.00K+107.6%
Q4 FY2018Dec 31, 2018$1.99M+208.2%
Q3 FY2018Sep 30, 2018-$1.12M–
Q2 FY2018Jun 30, 2018$108.00K–
Q1 FY2018Mar 31, 2018$236.00K-46.0%
Q4 FY2017Dec 31, 2017$646.00K–
Q3 FY2017Sep 30, 2017-$433.00K–
Q2 FY2017Jun 30, 2017-$1.19M–
Q1 FY2017Mar 31, 2017$437.00K–
Q4 FY2016Dec 31, 2016-$3.21M–
Q3 FY2016Sep 30, 2016-$3.44M–

More Xtant Medical figures

See a number that looks wrong?